Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.56 |
| ▸ | HPSE | Q9Y251 | 7/20 | 0.53 |
| ▸ | FGF2 | P09038 | 1/20 | 0.52 |
| ▸ | GBA1 | P04062 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | IGF2R | P11717 | 4/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13857778 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL20531001 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857784 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL18953026 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL21628176 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL21628175 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL16261556 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857782 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL21628177 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 | |
| SCHEMBL13857773 | 1.00 | AKT1 (0.56) | AKT1HPSEFGF2GBA1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003104248-A2 | DERIVATIVES OF URONIC (ALKYL-D-MANNOPYRANOSIDE) ACID, METHODS FOR THE PREPARATION THEREOF, AND APPLICATIONS THEREOF | CENTRE D'ETUDE ET DE VALORISATION DES ALGUES SA (FR) | 2003-12-18 | — | — | WO | disclosed |